Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

The National Road Investment Company (CNIR) has capitalised on European financial frameworks by signing the first two infrastructure contracts for the A8 Unirii (Union) Motorway.
A Russian Geran-2 combat drone breached Romanian airspace and crashed into a residential apartment block in the eastern city of Galați early on 29 May, intensifying security concerns along NATO's eastern flank.
The Board of Directors of Intesa Sanpaolo Bank Romania has acknowledged the resignation of Alessio Cioni from his roles as General Manager and Chairperson of the Management Committee (CEO).
Christian Tour, one of Romania's largest tour operators, has successfully completed its initial public offering (IPO), ahead of its listing on the BVB.
Electro-Alfa International, a Romanian manufacturer of electrical equipment and provider of EPC and IT services, reported revenue growth and profitability for Q1 2026. The company's total revenues reached €25.7 million, up 12.2% compared to Q1 2025. Net profit increased by 2.9% to €6.2 million, supported by a 2% increase in EBITDA, which reached €10.6 million.